SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-035524
Filing Date
2024-04-24
Accepted
2024-04-24 06:08:04
Documents
6
Period of Report
2024-04-24

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0204488-6k_mainz.htm 6-K 10897
2 ANNOUNCEMENT OF ANNUAL GENERAL MEETING ea020448801ex99-1_mainz.htm EX-99.1 1451
3 NOTICE OF ANNUAL GENERAL MEETING ea020448801ex99-2_mainz.htm EX-99.2 9997
4 AGENDA OF THE ANNUAL GENERAL MEETING ea020448801ex99-3_mainz.htm EX-99.3 44179
5 VOTING PROXY ea020448801ex99-4_mainz.htm EX-99.4 35311
6 ANNOUNCEMENT OF NOMINATIONS ea020448801ex99-5_mainz.htm EX-99.5 8433
  Complete submission text file 0001213900-24-035524.txt   111378
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 24866629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)